KMT2A and acute myeloid leukemia: In a similar fashion, the coagulation disorders, common in APL, are observed in other AML phenotypes, including both bleeding (e.g., KMT2a-rearranged AML [163,164]) and thrombotic events (reported in up to 15% of not-APL AMLs [7,165,166]).